These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7927804)

  • 1. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro.
    O'Brien L; Carmichael J; Lowrie DB; Andrew PW
    Infect Immun; 1994 Nov; 62(11):5187-90. PubMed ID: 7927804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion.
    Yu K; Mitchell C; Xing Y; Magliozzo RS; Bloom BR; Chan J
    Tuber Lung Dis; 1999; 79(4):191-8. PubMed ID: 10692986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of surface-active agents on Mycobacterium tuberculosis and Mycobacterium bovis. Obtaining chromogenic mycobacteria].
    Lafont J; Lafont P
    Can J Microbiol; 1978 Mar; 24(3):261-7. PubMed ID: 417788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties of selected drug-resistant strains of Mycobacterium tuberculosis].
    Afanas'eva IuP; Zagorzhinskiĭ PIu
    Probl Tuberk; 1978 Oct; (10):65-70. PubMed ID: 101985
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological properties of laboratory strains and clinical isolates of mycobacteria multiresistant to antitubercular preparations].
    Korneev AA; Golyshevskaia VI; Sevast'ianova EV; Safonova SG; Puzanov VA
    Probl Tuberk; 1999; (2):44-7. PubMed ID: 10420752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in virulence and resistance to pyrazinamide between M. bovis and M. tuberculosis.
    van Loenhout-Rooyackers JH
    Neth J Med; 1999 Sep; 55(3):163. PubMed ID: 10509077
    [No Abstract]   [Full Text] [Related]  

  • 7. Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv.
    Stewart GR; Ehrt S; Riley LW; Dale JW; McFadden J
    Tuber Lung Dis; 2000; 80(4-5):237-42. PubMed ID: 11052913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M. avium complex.
    Takii T; Abe C; Tamura A; Ramayah S; Belisle JT; Brennan PJ; Onozaki K
    J Interferon Cytokine Res; 2001 Mar; 21(3):187-96. PubMed ID: 11331042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial virulence factors.
    Gordon S; Andrew PW
    Soc Appl Bacteriol Symp Ser; 1996; 25():10S-22S. PubMed ID: 8972115
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cortisone-treatment on experimental mouse infection with pathogenic and saprophytic Mycobacteria.
    Kondo E; Kanai K
    Jpn J Med Sci Biol; 1977 Aug; 30(4):209-13. PubMed ID: 409870
    [No Abstract]   [Full Text] [Related]  

  • 11. Virulence of Mycobacterium avium in mice does not correlate with resistance to nitric oxide.
    Lousada S; Flórido M; Appelberg R
    Microb Pathog; 2007; 43(5-6):243-8. PubMed ID: 17683898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro.
    Firmani MA; Riley LW
    Infect Immun; 2002 Jul; 70(7):3965-8. PubMed ID: 12065545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro inhibition of mycobacteria by viridans streptococci.
    Allen BW
    J Med Microbiol; 1985 Apr; 19(2):227-35. PubMed ID: 3920400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIFFERENTIATION OF MYCOBACTERIA BY UTILIZATION OF NITRITE AS SOLE NITROGEN SOURCE.
    TSUKAMURA M; TSUKAMURA J
    J Bacteriol; 1965 May; 89(5):1442. PubMed ID: 14293023
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.
    Firmani MA; Riley LW
    J Clin Microbiol; 2002 Sep; 40(9):3162-6. PubMed ID: 12202547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different susceptibility of two animal species infected with isogenic mutants of Mycobacterium bovis identifies phoT as having roles in tuberculosis virulence and phosphate transport.
    Collins DM; Kawakami RP; Buddle BM; Wards BJ; de Lisle GW
    Microbiology (Reading); 2003 Nov; 149(Pt 11):3203-3212. PubMed ID: 14600232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide.
    Darwin KH; Ehrt S; Gutierrez-Ramos JC; Weich N; Nathan CF
    Science; 2003 Dec; 302(5652):1963-6. PubMed ID: 14671303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of mycobacteria, especially of Mycobacterium intracellulare, to 5-fluorouracil and pattern of development of resistance of Mycobacterium tuberculosis to the drug.
    Tsukamura M
    Microbiol Immunol; 1979; 23(5):427-9. PubMed ID: 116112
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar.
    Stottmeier KD; Beam RE; Kubica GP
    Am Rev Respir Dis; 1967 Nov; 96(5):1072-5. PubMed ID: 4964643
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
    Jeevan A; Yoshimura T; Foster G; McMurray DN
    Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.